These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8817399)

  • 1. Calcium channel blockers in the dock: innocent or guilty?
    Mackay JA; Sever PS
    J Hum Hypertens; 1996 May; 10(5):277-80. PubMed ID: 8817399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of calcium antagonists: more ACTION.
    Messerli FH; Staessen JA
    Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803
    [No Abstract]   [Full Text] [Related]  

  • 8. The calcium channel blocker debate.
    Owens P; O'Brien E
    Ir Med J; 1998; 91(5):158, 160-1. PubMed ID: 9973747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blockers: third-line antihypertensives.
    Prescrire Int; 2001 Aug; 10(54):121-3. PubMed ID: 11718186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained-release nifedipine: new indication. Angina: safer drugs are available.
    Prescrire Int; 1998 Jun; 7(35):71-3. PubMed ID: 10342920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers: an evidence-based review.
    Waters D
    Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel blockers for tocolysis: a review of their role and safety following reports of serious adverse events.
    Oei SG
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):137-45. PubMed ID: 16567033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
    Głuszek J; Pawlaczyk-Gabriel K
    Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotension and coronary events on nifedipine: reassessing nifedipine safety.
    Prescrire Int; 1998 Jun; 7(35):90-1. PubMed ID: 10342928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.
    Mehta JL; Subramanian VB
    Circulation; 1996 Apr; 93(7):1472; author reply 1473. PubMed ID: 8641039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.